Targeting ROS and cPLA2/COX2 Expressions Ameliorated Renal Damage in Obese Mice with Endotoxemia

Jia Feng Chang, Jih Chen Yeh, Chun Ta Ho, Shih Hao Liu, Chih Yu Hsieh, Ting Ming Wang, Shu Wei Chang, I. Ta Lee, Kuo Yang Huang, Jen Yu Wang, Wei Ning Lin

Research output: Contribution to journalArticle

Abstract

Obesity is associated with metabolic endotoxemia, reactive oxygen species (ROS), chronic inflammation, and obese kidney fibrosis. Although the fat-intestine-kidney axis has been documented, the pathomechanism and therapeutic targets of obese kidney fibrosis remain unelucidated. To mimic obese humans with metabolic endotoxemia, high-fat-diet-fed mice (HF group) were injected with lipopolysaccharide (LPS) to yield the obese kidney fibrosis-metabolic endotoxemia mouse model (HL group). Therapeutic effects of ROS, cytosolic phospholipases A2 (cPLA2) and cyclooxygenase-2 (COX-2) inhibitors were analyzed with a quantitative comparison of immunohistochemistry stains and morphometric approach in the tubulointerstitium of different groups. Compared with basal and HF groups, the HL group exhibited the most prominent obese kidney fibrosis, tubular epithelial lipid vacuoles, and lymphocyte infiltration in the tubulointerstitium. Furthermore, inhibitors of nonspecific ROS, cPLA2 and COX-2 ameliorated the above renal damages. Notably, the ROS-inhibitor-treated group ameliorated not only oxidative injury but also the expression of cPLA2 and COX-2, indicating that ROS functions as the upstream signaling molecule in the inflammatory cascade of obese kidney fibrosis. ROS acts as a key messenger in the signaling transduction of obese kidney fibrosis, activating downstream cPLA2 and COX-2. The given antioxidant treatment ameliorates obese kidney fibrosis resulting from a combined high-fat diet and LPS-ROS could serve as a potential therapeutic target of obese kidney fibrosis with metabolic endotoxemia.

Original languageEnglish
JournalInternational Journal of Molecular Sciences
Volume20
Issue number18
DOIs
Publication statusPublished - Sep 6 2019

Fingerprint

Cytosolic Phospholipases A2
Obese Mice
Endotoxemia
fibrosis
kidneys
mice
Reactive Oxygen Species
damage
Kidney
Fibrosis
Oxygen
oxygen
Cyclooxygenase 2
Oils and fats
fats
Fats
inhibitors
Nutrition
diets
Lipopolysaccharides

Keywords

  • cPLA2 and COX-2
  • endotoxemia
  • obese kidney fibrosis
  • ROS

ASJC Scopus subject areas

  • Catalysis
  • Molecular Biology
  • Spectroscopy
  • Computer Science Applications
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry

Cite this

Targeting ROS and cPLA2/COX2 Expressions Ameliorated Renal Damage in Obese Mice with Endotoxemia. / Chang, Jia Feng; Yeh, Jih Chen; Ho, Chun Ta; Liu, Shih Hao; Hsieh, Chih Yu; Wang, Ting Ming; Chang, Shu Wei; Lee, I. Ta; Huang, Kuo Yang; Wang, Jen Yu; Lin, Wei Ning.

In: International Journal of Molecular Sciences, Vol. 20, No. 18, 06.09.2019.

Research output: Contribution to journalArticle

Chang, JF, Yeh, JC, Ho, CT, Liu, SH, Hsieh, CY, Wang, TM, Chang, SW, Lee, IT, Huang, KY, Wang, JY & Lin, WN 2019, 'Targeting ROS and cPLA2/COX2 Expressions Ameliorated Renal Damage in Obese Mice with Endotoxemia', International Journal of Molecular Sciences, vol. 20, no. 18. https://doi.org/10.3390/ijms20184393
Chang, Jia Feng ; Yeh, Jih Chen ; Ho, Chun Ta ; Liu, Shih Hao ; Hsieh, Chih Yu ; Wang, Ting Ming ; Chang, Shu Wei ; Lee, I. Ta ; Huang, Kuo Yang ; Wang, Jen Yu ; Lin, Wei Ning. / Targeting ROS and cPLA2/COX2 Expressions Ameliorated Renal Damage in Obese Mice with Endotoxemia. In: International Journal of Molecular Sciences. 2019 ; Vol. 20, No. 18.
@article{50e254c26f7146528ad69377dd6bdea0,
title = "Targeting ROS and cPLA2/COX2 Expressions Ameliorated Renal Damage in Obese Mice with Endotoxemia",
abstract = "Obesity is associated with metabolic endotoxemia, reactive oxygen species (ROS), chronic inflammation, and obese kidney fibrosis. Although the fat-intestine-kidney axis has been documented, the pathomechanism and therapeutic targets of obese kidney fibrosis remain unelucidated. To mimic obese humans with metabolic endotoxemia, high-fat-diet-fed mice (HF group) were injected with lipopolysaccharide (LPS) to yield the obese kidney fibrosis-metabolic endotoxemia mouse model (HL group). Therapeutic effects of ROS, cytosolic phospholipases A2 (cPLA2) and cyclooxygenase-2 (COX-2) inhibitors were analyzed with a quantitative comparison of immunohistochemistry stains and morphometric approach in the tubulointerstitium of different groups. Compared with basal and HF groups, the HL group exhibited the most prominent obese kidney fibrosis, tubular epithelial lipid vacuoles, and lymphocyte infiltration in the tubulointerstitium. Furthermore, inhibitors of nonspecific ROS, cPLA2 and COX-2 ameliorated the above renal damages. Notably, the ROS-inhibitor-treated group ameliorated not only oxidative injury but also the expression of cPLA2 and COX-2, indicating that ROS functions as the upstream signaling molecule in the inflammatory cascade of obese kidney fibrosis. ROS acts as a key messenger in the signaling transduction of obese kidney fibrosis, activating downstream cPLA2 and COX-2. The given antioxidant treatment ameliorates obese kidney fibrosis resulting from a combined high-fat diet and LPS-ROS could serve as a potential therapeutic target of obese kidney fibrosis with metabolic endotoxemia.",
keywords = "cPLA2 and COX-2, endotoxemia, obese kidney fibrosis, ROS",
author = "Chang, {Jia Feng} and Yeh, {Jih Chen} and Ho, {Chun Ta} and Liu, {Shih Hao} and Hsieh, {Chih Yu} and Wang, {Ting Ming} and Chang, {Shu Wei} and Lee, {I. Ta} and Huang, {Kuo Yang} and Wang, {Jen Yu} and Lin, {Wei Ning}",
year = "2019",
month = "9",
day = "6",
doi = "10.3390/ijms20184393",
language = "English",
volume = "20",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "MDPI AG",
number = "18",

}

TY - JOUR

T1 - Targeting ROS and cPLA2/COX2 Expressions Ameliorated Renal Damage in Obese Mice with Endotoxemia

AU - Chang, Jia Feng

AU - Yeh, Jih Chen

AU - Ho, Chun Ta

AU - Liu, Shih Hao

AU - Hsieh, Chih Yu

AU - Wang, Ting Ming

AU - Chang, Shu Wei

AU - Lee, I. Ta

AU - Huang, Kuo Yang

AU - Wang, Jen Yu

AU - Lin, Wei Ning

PY - 2019/9/6

Y1 - 2019/9/6

N2 - Obesity is associated with metabolic endotoxemia, reactive oxygen species (ROS), chronic inflammation, and obese kidney fibrosis. Although the fat-intestine-kidney axis has been documented, the pathomechanism and therapeutic targets of obese kidney fibrosis remain unelucidated. To mimic obese humans with metabolic endotoxemia, high-fat-diet-fed mice (HF group) were injected with lipopolysaccharide (LPS) to yield the obese kidney fibrosis-metabolic endotoxemia mouse model (HL group). Therapeutic effects of ROS, cytosolic phospholipases A2 (cPLA2) and cyclooxygenase-2 (COX-2) inhibitors were analyzed with a quantitative comparison of immunohistochemistry stains and morphometric approach in the tubulointerstitium of different groups. Compared with basal and HF groups, the HL group exhibited the most prominent obese kidney fibrosis, tubular epithelial lipid vacuoles, and lymphocyte infiltration in the tubulointerstitium. Furthermore, inhibitors of nonspecific ROS, cPLA2 and COX-2 ameliorated the above renal damages. Notably, the ROS-inhibitor-treated group ameliorated not only oxidative injury but also the expression of cPLA2 and COX-2, indicating that ROS functions as the upstream signaling molecule in the inflammatory cascade of obese kidney fibrosis. ROS acts as a key messenger in the signaling transduction of obese kidney fibrosis, activating downstream cPLA2 and COX-2. The given antioxidant treatment ameliorates obese kidney fibrosis resulting from a combined high-fat diet and LPS-ROS could serve as a potential therapeutic target of obese kidney fibrosis with metabolic endotoxemia.

AB - Obesity is associated with metabolic endotoxemia, reactive oxygen species (ROS), chronic inflammation, and obese kidney fibrosis. Although the fat-intestine-kidney axis has been documented, the pathomechanism and therapeutic targets of obese kidney fibrosis remain unelucidated. To mimic obese humans with metabolic endotoxemia, high-fat-diet-fed mice (HF group) were injected with lipopolysaccharide (LPS) to yield the obese kidney fibrosis-metabolic endotoxemia mouse model (HL group). Therapeutic effects of ROS, cytosolic phospholipases A2 (cPLA2) and cyclooxygenase-2 (COX-2) inhibitors were analyzed with a quantitative comparison of immunohistochemistry stains and morphometric approach in the tubulointerstitium of different groups. Compared with basal and HF groups, the HL group exhibited the most prominent obese kidney fibrosis, tubular epithelial lipid vacuoles, and lymphocyte infiltration in the tubulointerstitium. Furthermore, inhibitors of nonspecific ROS, cPLA2 and COX-2 ameliorated the above renal damages. Notably, the ROS-inhibitor-treated group ameliorated not only oxidative injury but also the expression of cPLA2 and COX-2, indicating that ROS functions as the upstream signaling molecule in the inflammatory cascade of obese kidney fibrosis. ROS acts as a key messenger in the signaling transduction of obese kidney fibrosis, activating downstream cPLA2 and COX-2. The given antioxidant treatment ameliorates obese kidney fibrosis resulting from a combined high-fat diet and LPS-ROS could serve as a potential therapeutic target of obese kidney fibrosis with metabolic endotoxemia.

KW - cPLA2 and COX-2

KW - endotoxemia

KW - obese kidney fibrosis

KW - ROS

UR - http://www.scopus.com/inward/record.url?scp=85071976240&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071976240&partnerID=8YFLogxK

U2 - 10.3390/ijms20184393

DO - 10.3390/ijms20184393

M3 - Article

C2 - 31500176

AN - SCOPUS:85071976240

VL - 20

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 18

ER -